Article Details


Computational Molecular Modeling of Compounds from Amaryllidaceae Family as Potential Acetylcholinesterase Inhibitors

[ Vol. 13 , Issue. 2 ]

Author(s):

Maiara de F. de B. Brito, Jaderson V. Ferreira, Lucilene R. de Souza, Laira R.P. Gemaque, Kessia P.A. Sousa, Cesar F. dos Santos, Francinaldo S. Braga, Larissa Pernomian, Carlos H.T.P. da Silva, Cleydson B.R. Santos, Carlton A. Taft and Lorane I.S. Hage-Melim   Pages 121 - 129 ( 9 )

Abstract:


Background: Alzheimer's disease (AD) is a neurodegenerative and irreversible disease that inevitably progresses to the death. The usage of acetylcholinesterase (AChE) inhibitors has been effective in reducing the symptoms of this disease. This study aims to examine the compounds from the species of Amaryllidaceae family as a source for active compounds able to inhibit AChE and contribute to the treatment of AD.

Methods: Molecular modeling was done with DFT/B3lyp/6-31G** method for the compounds: Galantamine, Assoanine, Oxoassoanine, Epinorgalatamine, Hidroxygalantamine and Sanguinine. Potential electrostatic maps and frontier orbital were calculated to investigate the likely sites of biological activity of the compounds. The Pearson correlation was performed between the calculated descriptors and the total energy to evaluate the descriptors that have better correlations. Similarly, correlation of the calculated descriptors was performed with the hydration energy. Predictions of pharmacokinetic and toxicological properties (mutagenicity and carcinogenicity) were obtained for the studied compounds.

Results: The molecule with the highest GAP was epinorgalantamine, which indicates greater stability and lower reactivity than sanguinine that showed low stability and increased chemical reactivity. Sanguinine, galantamine and epinorgalantamine molecules showed good pharmacokinetic results. Epinorgalantamine and hidroxygalantamine did not exhibit mutagenicity.

Conclusion: Epinorgalantamine showed the most satisfactory pharmacokinetic and toxicological results when compared to the parameters obtained from the other compounds investigated. However, more work is still required so that, in the future, the use of natural compounds can contribute to the treatment of patients with AD.

Keywords:

Alzheimer's disease, acetylcholinesterase, Amaryllidaceae, alkaloids, inhibitors, neurodegenerative disease.

Affiliation:

Departamento de Ciencias Biologicas e da Saude, Universidade Federal do Amapa, Macapa, Amapa, Departamento de Ciencias Biologicas e da Saude, Universidade Federal do Amapa, Macapa, Amapa, Departamento de Ciencias Biologicas e da Saude, Universidade Federal do Amapa, Macapa, Amapa, Departamento de Ciencias Biologicas e da Saude, Universidade Federal do Amapa, Macapa, Amapa, Departamento de Ciencias Biologicas e da Saude, Universidade Federal do Amapa, Macapa, Amapa, Departamento de Ciencias Biologicas e da Saude, Universidade Federal do Amapa, Macapa, Amapa, Departamento de Ciencias Biologicas e da Saude, Universidade Federal do Amapa, Macapa, Amapa, Departamento de Ciencias Farmaceuticas, Faculdade de Ciencias Farmaceuticas de Ribeirao Preto, Universidade de Sao Paulo, Ribeirao Preto, Sao Paulo, Departamento de Ciencias Farmaceuticas, Faculdade de Ciencias Farmaceuticas de Ribeirao Preto, Universidade de Sao Paulo, Ribeirao Preto, Sao Paulo, Departamento de Ciencias Farmaceuticas, Faculdade de Ciencias Farmaceuticas de Ribeirao Preto, Universidade de Sao Paulo, Ribeirao Preto, Sao Paulo, Centro Brasileiro de Pesquisas Fisicas, Rio de Janeiro, Departamento de Ciencias Biologicas e da Saude, Universidade Federal do Amapa, Macapa, Amapa

Graphical Abstract:



Read Full-Text article